Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Multicenter, Randomized, Placebo-Controlled Single Dose Study to Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches

NCT00434083 is registered in ClinicalTrials.gov with POZEN as lead sponsor.

NCT NCT00434083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00434083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Multicenter, Randomized, Placebo-Controlled Single Dose Study to Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches
Lead sponsor
POZEN
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2004
Completion date
January 31, 2005
Enrollment
1,200
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headaches